Together Pharma Ltd (TASE: TGTR)
Health Care · Pharmaceuticals · IL
₪2.24
-2.53% today · -44.1% 1Y
Together Pharma Ltd (TASE: TGTR) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $12.97M and employs 210 people.
Over the last twelve months the share price has lost 44.1%, trading between 2.14 and 4.10.
Tweenvest scores Together Pharma Ltd across four factors: quality 53/100, value 55/100. Its strongest factor is value.
TGTR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $12.97M
- Revenue (TTM)
- $34.39M
- P/E
- 18.63
- EPS
- 0.12
- Dividend yield
- —
- Beta (5Y)
- 0.19
- 52-week high
- ₪4.10
- 52-week low
- ₪2.14
- Avg volume (3M)
- —
- Shares outstanding
- 17.35M
- Employees
- 210
- Next earnings
- —
About Together Pharma Ltd
Together Pharma Ltd, through its subsidiaries, engages in the cultivation, propagation, import, export, production, storage and distribution of medical cannabis products in Israel. It offers cannabis oils and inflorescences. The company was incorporated in 1991 and is based in Ashkelon, Israel.
- ISIN
- IL0004620105
- Founded
- 1991
- Listed since
- Aug 12, 2002
- Exchange
- The Tel-Aviv Stock Exchange
- Currency
- ILS
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,235.36 | +0.14% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.50 | +0.13% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $155.85 | -0.38% |
| Roche Holding AGSWX: ROP | $371.62B | CHF370.90 | -0.78% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £123.18 | -1.27% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.51 | -0.21% |
Figures last refreshed Aug 18, 2026.